Skip to search.
 TSX Down 0.62% TSX Ventures Down 0.53%

BioCryst Pharmaceuticals, Inc. (BCRX)

-NasdaqGS
3.43 Up 0.17(5.21%) 4:00PM EDT
Prev Close:3.26
Open:3.29
Bid:3.29 x 300
Ask:3.52 x 2600
1y Target Est:6.56
Beta:3.36948
Next Earnings Date: 5-May-16BCRX Earnings announcement
Day's Range:3.17 - 3.44
52wk Range:1.63 - 16.83
Volume:957,335
Avg Vol (3m):1,609,620
Market Cap:252.75M
P/E (ttm):N/A
EPS (ttm):-0.59
Div & Yield:N/A (N/A)
Quotes delayed, except where indicated otherwise. Currency in USD.

Comparison

Symbol% ChgMkt Cap
BCRXUp 5.21%252.75M
GSKUp 0.89%104.76B

Key Statistics

Forward P/E (1 yr):N/A
P/S (ttm):4.95
Ex-Dividend Date:N/A

Analysts

Annual EPS Est (Dec-16) :-0.97
Quarterly EPS Est (Mar-16) :-0.23
Mean Recommendation*:2.6
PEG Ratio (5 yr expected):-0.17

* (Strong Buy) 1.0 - 5.0 (Sell)

Analyst Opinion | Estimates

Business Summary

BioCryst Pharmaceuticals, Inc., a biotechnology company, designs, optimizes, and develops small molecule drugs that block key enzymes involved in the pathogenesis of diseases. View More
Your browser doesn't support canvas
SETTINGS
Scrolling
Speed
Display
Price
Submit Feedback